Moody Aldrich Partners LLC Editas Medicine, Inc. Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$26.55 - $40.57 $1.42 Million - $2.18 Million
-53,631 Closed
0 $0
Q3 2021

Oct 29, 2021
BUY
$39.27 - $72.94 $2.11 Million - $3.91 Million
53,631 New
53,631 $2.2 Million
Q2 2018

Aug 13, 2018
SELL
$31.4 - $41.01 $654,250 - $854,484
-20,836 Closed
0 $0
Q1 2018

Apr 26, 2018
BUY
$29.84 - $44.08 $621,746 - $918,450
20,836 New
20,836 $691,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $183M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email